JPS59155312A - 新規薬理製剤 - Google Patents

新規薬理製剤

Info

Publication number
JPS59155312A
JPS59155312A JP59024236A JP2423684A JPS59155312A JP S59155312 A JPS59155312 A JP S59155312A JP 59024236 A JP59024236 A JP 59024236A JP 2423684 A JP2423684 A JP 2423684A JP S59155312 A JPS59155312 A JP S59155312A
Authority
JP
Japan
Prior art keywords
pharmacological
pellet
releases
acid
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59024236A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0451528B2 (enExample
Inventor
エリク・ヨハネス・デイドリクセン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of JPS59155312A publication Critical patent/JPS59155312A/ja
Publication of JPH0451528B2 publication Critical patent/JPH0451528B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP59024236A 1983-02-11 1984-02-10 新規薬理製剤 Granted JPS59155312A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK589/83 1983-02-11
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (2)

Publication Number Publication Date
JPS59155312A true JPS59155312A (ja) 1984-09-04
JPH0451528B2 JPH0451528B2 (enExample) 1992-08-19

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59024236A Granted JPS59155312A (ja) 1983-02-11 1984-02-10 新規薬理製剤

Country Status (15)

Country Link
US (1) US4600577A (enExample)
JP (1) JPS59155312A (enExample)
BE (1) BE898882A (enExample)
DE (1) DE3404595A1 (enExample)
DK (1) DK58983D0 (enExample)
ES (1) ES8608490A1 (enExample)
FR (1) FR2540727B1 (enExample)
GB (1) GB2134785B (enExample)
IE (1) IE56604B1 (enExample)
IT (1) IT1196682B (enExample)
NL (1) NL8400430A (enExample)
NZ (1) NZ207010A (enExample)
PH (1) PH21734A (enExample)
SE (1) SE447871B (enExample)
ZA (1) ZA84856B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0256418A (ja) * 1988-06-30 1990-02-26 Klinge Pharm Gmbh & Co 新規医薬製剤およびその製造方法
JP2002537319A (ja) * 1999-02-26 2002-11-05 アンドルックス ファーマスーティカルズ インコーポレーテッド 放出制御されたブプロピオン製剤

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
PT1146862E (pt) 1999-01-29 2003-09-30 Disphar Int Bv Composicoes farmaceuticas
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
JP5502254B2 (ja) * 2001-01-31 2014-05-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 少なくとも２種類の異なる被覆ペレット形から成る多粒子剤形
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
BRPI0818286A2 (pt) 2007-10-12 2020-08-11 Takeda Pharmaceuticals North America, Inc. métodos de tratamento de distúrbios gastrointestinais independente da ingestão de alimento.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0256418A (ja) * 1988-06-30 1990-02-26 Klinge Pharm Gmbh & Co 新規医薬製剤およびその製造方法
JP2002537319A (ja) * 1999-02-26 2002-11-05 アンドルックス ファーマスーティカルズ インコーポレーテッド 放出制御されたブプロピオン製剤

Also Published As

Publication number Publication date
SE8400723D0 (sv) 1984-02-10
JPH0451528B2 (enExample) 1992-08-19
FR2540727A1 (fr) 1984-08-17
PH21734A (en) 1988-02-10
IT1196682B (it) 1988-11-25
IE56604B1 (en) 1991-10-09
NZ207010A (en) 1987-06-30
ZA84856B (en) 1984-09-26
IT8467131A1 (it) 1985-08-13
SE447871B (sv) 1986-12-22
US4600577A (en) 1986-07-15
IE840146L (en) 1984-08-11
NL8400430A (nl) 1984-09-03
ES529660A0 (es) 1986-06-16
SE8400723L (sv) 1984-08-12
DE3404595A1 (de) 1984-08-16
GB2134785A (en) 1984-08-22
ES8608490A1 (es) 1986-06-16
GB8403572D0 (en) 1984-03-14
GB2134785B (en) 1986-07-02
BE898882A (fr) 1984-08-10
DK58983D0 (da) 1983-02-11
IT8467131A0 (it) 1984-02-13
FR2540727B1 (fr) 1987-01-23
DE3404595C2 (enExample) 1993-04-29

Similar Documents

Publication Publication Date Title
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
FI78835C (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
RU2095054C1 (ru) Твердая лекарственная форма для орального введения
US6348469B1 (en) Solid compositions containing glipizide and polyethylene oxide
JP5828614B2 (ja) ジアルキルフマレート含有薬剤調合物
US5019398A (en) Pharmaceutical composition providing the sustained-release of valproic acid
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
CS244909B2 (en) Production method of retarded form of bromohexine
JP2002525276A (ja) フマル酸誘導体を含有する移植医療における治療剤
JPS59155312A (ja) 新規薬理製剤
TW200522981A (en) Immediate-release formulation of acid-labile pharmaceutical compositions
CZ284382B6 (cs) Pevná léková forma s řízeným uvolňováním účinné látky
NZ201008A (en) Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient
JP2001526213A (ja) 経口医薬パルス放出剤形
JP2001199878A (ja) 酸に不安定ベンズイミダゾールを含有する修飾された放出特性の経口用固形製剤
JPS63139128A (ja) Ｌ―ドーパ含有組成物
JPH037238A (ja) 持続性製剤用薬物放出制御膜
HK175796A (en) Oral dosage forms containing pimobendan
WO2017018473A1 (ja) 錠剤
JPH09510430A (ja) 制御された放出のカリウム投与形状
KR100429694B1 (ko) 밸프로산금속염의서방성정제
PL192648B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu, zawierający inhibitor ACE jako substancję aktywną
JPH0157090B2 (enExample)
WO2005053659A1 (en) An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
JPH0260643B2 (enExample)